{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:06:15Z","timestamp":1791198375870,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T00:00:00Z","timestamp":1401148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-11-1-0708"],"award-info":[{"award-number":["W81XWH-11-1-0708"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.neulet.2014.05.044","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T11:47:13Z","timestamp":1401364033000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection"],"prefix":"10.1016","volume":"576","author":[{"given":"Jesse R.","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaynor A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Beagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope J.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neulet.2014.05.044_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.neulet.2014.05.044_bib0010","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.neulet.2014.05.044_bib0015","doi-asserted-by":"crossref","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.neulet.2014.05.044_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.neulet.2014.05.044_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156652311795684759","article-title":"Adeno-associated virus (AAV) vectors in the CNS","volume":"11","author":"McCown","year":"2011","journal-title":"Curr. Gene Ther."},{"issue":"18","key":"10.1016\/j.neulet.2014.05.044_bib0030","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182904faa","article-title":"Safety\/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients","volume":"80","author":"Bartus","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neulet.2014.05.044_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/hum.2011.220","article-title":"Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease","volume":"23","author":"Mittermeyer","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.neulet.2014.05.044_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.neulet.2014.05.044_bib0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/mt.2011.98","article-title":"Several rAAV vectors efficiently cross the blood\u2013brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.neulet.2014.05.044_bib0050","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.neulet.2014.05.044_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neulet.2014.05.044_bib0060","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1038\/mtna.2013.27","article-title":"Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia","volume":"2","author":"Haddad","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.neulet.2014.05.044_bib0065","doi-asserted-by":"crossref","first-page":"e67680","DOI":"10.1371\/journal.pone.0067680","article-title":"Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain","volume":"8","author":"Chakrabarty","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.neulet.2014.05.044_bib0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/14712598.2012.681463","article-title":"The advent of AAV9 expands applications for brain and spinal cord gene delivery","volume":"12","author":"Dayton","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.neulet.2014.05.044_bib0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mt.2009.15","article-title":"AAV9: a potential blood\u2013brain barrier buster","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.neulet.2014.05.044_bib0080","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.neulet.2014.05.044_bib0085","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.neulet.2014.05.044_bib0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.neulet.2014.05.044_bib0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/hum.2011.166","article-title":"Decreasing disease severity in symptomatic, Smn(\u2212\/\u2212);SMN2(+\/+), spinal muscular atrophy mice following scAAV9-SMN delivery","volume":"23","author":"Glascock","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.neulet.2014.05.044_bib0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2011.11.121","article-title":"Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy","volume":"417","author":"Glascock","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2014.05.044_bib0105","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddu169","article-title":"Defining the therapeutic window in a severe animal model of Spinal Muscular Atrophy","author":"Robbins","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"35","key":"10.1016\/j.neulet.2014.05.044_bib0110","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.neulet.2014.05.044_bib0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neulet.2014.05.044_bib0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-61779-095-9_10","article-title":"Manufacturing of adeno-associated viruses, for example: AAV2","volume":"737","author":"Chen","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"56","key":"10.1016\/j.neulet.2014.05.044_bib0125","doi-asserted-by":"crossref","DOI":"10.3791\/2968","article-title":"Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice","author":"Glascock","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"24","key":"10.1016\/j.neulet.2014.05.044_bib0130","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","article-title":"Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector","volume":"75","author":"Passini","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.neulet.2014.05.044_bib0135","series-title":"Comparative Cytoarchitectonic Atlas of the C57BL\/6 and 129\/Sv Mouse Brains","author":"Hof","year":"2000"},{"issue":"11","key":"10.1016\/j.neulet.2014.05.044_bib0140","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.neulet.2014.05.044_bib0145","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/mt.2008.166","article-title":"Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain","volume":"16","author":"Cearley","year":"2008","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.neulet.2014.05.044_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.mt.6300331","article-title":"AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method","volume":"16","author":"Klein","year":"2008","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.neulet.2014.05.044_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1566523044578077","article-title":"Promoters and control elements: designing expression cassettes for gene therapy","volume":"4","author":"Papadakis","year":"2004","journal-title":"Curr. Gene Ther."},{"issue":"7","key":"10.1016\/j.neulet.2014.05.044_bib0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jgm.381","article-title":"Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used","volume":"5","author":"Glover","year":"2003","journal-title":"J. Gene Med."},{"issue":"4","key":"10.1016\/j.neulet.2014.05.044_bib0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.gt.3301905","article-title":"Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area","volume":"10","author":"Kugler","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.neulet.2014.05.044_bib0170","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2013.021","article-title":"Intracerebroventricular Injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord","author":"Dirren","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"7","key":"10.1016\/j.neulet.2014.05.044_bib0175","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mt.2013.88","article-title":"Selective forelimb impairment in rats expressing a pathological TDP-43 25kDa C-terminal fragment to mimic amyotrophic lateral sclerosis","volume":"21","author":"Dayton","year":"2013","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.neulet.2014.05.044_bib0180","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/mt.2010.191","article-title":"Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed","volume":"18","author":"Wang","year":"2010","journal-title":"Mol. Ther."},{"issue":"46","key":"10.1016\/j.neulet.2014.05.044_bib0185","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1523\/JNEUROSCI.2795-06.2006","article-title":"Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice","volume":"26","author":"Levites","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014004169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014004169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T23:47:50Z","timestamp":1565480870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014004169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":37,"alternative-id":["S0304394014004169"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.05.044","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}